— Know what they know.
Not Investment Advice
Also trades as: 4293.T (JPX) · $vol 2M

SPIDY OTC

Septeni Holdings Co., Ltd.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -18.7% 5Y: -42.3%
$2.13
+0.00 (+0.00%)
 
OTC · Communication Services · Advertising Agencies · Tech Score Sell · Power 44 · $441.9M mcap · 57M float · 0.0002% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$441.9M
52W Range2.13-2.13
Volume101
Avg Volume86
Beta0.17
Dividend$0.23
Analyst Ratings
No analyst coverage
Company Info
CEOYuichi Kouno
Employees1,674
SectorCommunication Services
IndustryAdvertising Agencies
IPO Date2013-04-03
Sumitomo Fudosan Shinjuku Grand Tower
Tokyo, TY 160-6130
JP
81 3 6863 5623
About Septeni Holdings Co., Ltd.

Septeni Holdings Co., Ltd., a Tokyo-headquartered company founded in 1990, engages in a broad spectrum of digital marketing and media platform operations, both within Japan and internationally. Its diverse service offerings encompass cloud-based customer relationship management (CRM) solutions and mobile advertising. The company also supports the creative sector by nurturing Manga artists and distributing their works through digital channels. Furthermore, Septeni Holdings manages several distinct platforms: ViViViT, a recruitment service connecting aspiring IT engineers and web designers with potential employers; gooddo, which facilitates social contribution initiatives; and Pharmarket, a specialized platform enabling pharmacies to exchange surplus inventory. Beyond these ventures, the company provides incubation support, aiding new businesses from their foundational stages. The entity adopted its current name, Septeni Holdings Co., Ltd., in October 2006, having previously been known as Septeni Co., Ltd.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms